8.16 USD
↗ 0.22 (2.71%)LIVE (AS OF 12:08 PM EDT)
Absci Corporation Common Stock
ABSINASDAQ • USD
Market: OPEN
ABSI is currently priced at $8.16. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, ABSI trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Sep 15, 2026.
Open?$8.02
High?$8.20
Low?$7.95
Prev. Close?$7.94
Volume?851.5K
Avg. Volume?2.7M
VWAP?$8.07
Rel. Volume?0.31x
Bid / Ask
Bid?$8.14 × 100
Ask?$8.15 × 1.2K
Spread?$0.01
Midpoint?$8.15
Valuation & Ratios
Market Cap?1.4B
Shares Out?171.6M
Float?119.4M
Float %?69.6%
P/E Ratio?N/A
P/B Ratio?5.54
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Themes
Employees
140
Market Cap
1.4B
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Website
Listed
2021-07-22
Address
18105 SE MILL PLAIN BLVD
VANCOUVER, WA 98683
Phone: (360) 949-1041
VANCOUVER, WA 98683
Phone: (360) 949-1041
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?100
Momentum?50
Short Sent.?30
Piotroski F-Score?2/9Weak
Altman Z-Score?55.90Safe
Confidence?51%Low
Short InterestSqueeze Risk
Short % of Float?30.82%Squeeze Risk
Short Interest?36.8M
Days to Cover?12.5
Free Float119.4M
Avg Daily Volume2.9M
Settlement Date2026-08-31
Financial Health
Current Ratio?10.63Strong
Quick Ratio?10.63Strong
Cash Ratio?5.50Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?5.54FAIR▾
Peers100
S&P33
P/S?872.91HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-10.9CHEAP▾
S&P97
EV/Sales?803.91HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-49.2%WEAK▾
S&P3
ROA?-45.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-108974000
Enterprise Value?$1.3B
Fundamentals ratios updated end of day